Header Logo

Connection

Michael Bolaris to Anti-Bacterial Agents

This is a "connection" page, showing publications Michael Bolaris has written about Anti-Bacterial Agents.
Connection Strength

1.270
  1. 28 NICUs participating in a quality improvement collaborative targeting early-onset sepsis antibiotic use. J Perinatol. 2024 Jul; 44(7):1061-1068.
    View in: PubMed
    Score: 0.214
  2. Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin. Clin Microbiol Infect. 2021 Sep; 27(9):1346.e1-1346.e7.
    View in: PubMed
    Score: 0.171
  3. Detection of carbapenem resistant enterobacteriace from fomite surfaces. Am J Infect Control. 2021 01; 49(1):128-130.
    View in: PubMed
    Score: 0.165
  4. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med. 2019 02 14; 380(7):638-650.
    View in: PubMed
    Score: 0.151
  5. Early onset sepsis calculator-based management of newborns exposed to maternal intrapartum fever: a cost benefit analysis. J Perinatol. 2019 04; 39(4):571-580.
    View in: PubMed
    Score: 0.151
  6. Clinicocytopathologic correlation in an atypical presentation of lymphadenopathy with review of literature. Am J Clin Pathol. 2015 May; 143(5):749-54.
    View in: PubMed
    Score: 0.116
  7. Diabetic murine models for Acinetobacter baumannii infection. J Antimicrob Chemother. 2012 Jun; 67(6):1439-45.
    View in: PubMed
    Score: 0.093
  8. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011 Jul 15; 53(2):158-63.
    View in: PubMed
    Score: 0.089
  9. Chlorhexidine and Mupirocin for Clearance of Methicillin-Resistant Staphylococcus aureus Colonization After Hospital Discharge: A Secondary Analysis of the Changing Lives by Eradicating Antibiotic Resistance Trial. Clin Infect Dis. 2023 02 08; 76(3):e1208-e1216.
    View in: PubMed
    Score: 0.050
  10. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathog. 2018 05; 14(5):e1007056.
    View in: PubMed
    Score: 0.036
  11. Cryptococcus gattii Meningitis Complicated by Listeria monocytogenes Infection. Emerg Infect Dis. 2016 09; 22(9):1669-71.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.